N
NewGLab Pharma Co Ltd
KOSDAQ:214870
NewGLab Pharma Co Ltd
KOSDAQ:214870
Price:
6 915
KRW
-27.44%
Market Closed
Market Cap:
₩439.9m
Balance Sheet
Balance Sheet Decomposition
NewGLab Pharma Co Ltd
NewGLab Pharma Co Ltd
Balance Sheet Decomposition is not available for
NewGLab Pharma Co Ltd
NewGLab Pharma Co Ltd
Balance Sheet
NewGLab Pharma Co Ltd
NewGLab Pharma Co Ltd
Currency: KRW
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
11 408
|
5 548
|
38 430
|
14 806
|
43 186
|
44 041
|
32 879
|
6 859
|
524
|
732
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
200
|
0
|
|
| Cash Equivalents |
11 408
|
5 548
|
38 430
|
14 806
|
43 186
|
44 041
|
32 879
|
6 859
|
324
|
732
|
|
| Short-Term Investments |
2 105
|
12 216
|
12 751
|
24 410
|
80
|
130
|
10 589
|
4 180
|
4 000
|
10
|
|
| Total Receivables |
7 707
|
8 346
|
4 594
|
3 686
|
27 509
|
41 911
|
14 715
|
4 005
|
13 165
|
1 454
|
|
| Accounts Receivables |
6 767
|
8 346
|
4 594
|
3 686
|
25 482
|
23 604
|
9 185
|
2 840
|
1 043
|
1 278
|
|
| Other Receivables |
940
|
0
|
0
|
0
|
2 027
|
18 307
|
5 529
|
1 165
|
12 122
|
175
|
|
| Inventory |
10 120
|
6 588
|
5 867
|
3 716
|
18 353
|
9 469
|
2 744
|
2 771
|
970
|
942
|
|
| Other Current Assets |
101
|
68
|
410
|
1 986
|
871
|
4 234
|
17 440
|
4 140
|
418
|
135
|
|
| Total Current Assets |
31 441
|
32 764
|
62 052
|
48 604
|
89 999
|
99 785
|
78 367
|
21 955
|
19 077
|
3 272
|
|
| PP&E Net |
7 887
|
9 831
|
9 552
|
5 209
|
5 391
|
5 248
|
7 412
|
6 594
|
2 318
|
4 857
|
|
| PP&E Gross |
7 887
|
0
|
0
|
0
|
5 391
|
5 248
|
7 412
|
6 594
|
2 318
|
4 857
|
|
| Accumulated Depreciation |
3 394
|
0
|
0
|
0
|
5 318
|
5 710
|
7 313
|
14 330
|
11 486
|
9 669
|
|
| Intangible Assets |
530
|
997
|
1 423
|
923
|
5 471
|
5 108
|
8 895
|
265
|
258
|
145
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
10 069
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
40
|
0
|
|
| Long-Term Investments |
1 662
|
100
|
317
|
4 008
|
8 405
|
8 881
|
0
|
60
|
4
|
4
|
|
| Other Long-Term Assets |
266
|
849
|
11
|
0
|
7 919
|
8 006
|
9 035
|
1 072
|
8 542
|
4 247
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
10 069
|
0
|
0
|
0
|
|
| Total Assets |
41 786
N/A
|
44 542
+7%
|
73 354
+65%
|
58 745
-20%
|
117 184
+99%
|
127 028
+8%
|
113 779
-10%
|
29 946
-74%
|
30 239
+1%
|
12 526
-59%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
3 099
|
6 133
|
3 533
|
1 887
|
6 887
|
811
|
1 308
|
1 425
|
554
|
865
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
140
|
85
|
268
|
364
|
2 535
|
3 139
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
767
|
980
|
891
|
1 195
|
|
| Current Portion of Long-Term Debt |
0
|
1 708
|
9 644
|
24 572
|
34 561
|
53 373
|
54 100
|
36 576
|
36 032
|
18 359
|
|
| Other Current Liabilities |
1 814
|
34
|
5
|
38
|
4 596
|
3 772
|
22 138
|
10 388
|
10 256
|
6 995
|
|
| Total Current Liabilities |
4 913
|
7 876
|
13 182
|
26 497
|
46 184
|
58 042
|
78 581
|
49 734
|
50 267
|
30 554
|
|
| Long-Term Debt |
1 577
|
2 856
|
21 475
|
0
|
4 096
|
4 956
|
3 748
|
711
|
625
|
255
|
|
| Deferred Income Tax |
0
|
0
|
855
|
454
|
1 040
|
725
|
2 484
|
935
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
126
|
2 298
|
3 324
|
2 575
|
|
| Other Liabilities |
103
|
0
|
0
|
0
|
0
|
0
|
171
|
288
|
165
|
238
|
|
| Total Liabilities |
6 593
N/A
|
10 732
+63%
|
35 512
+231%
|
26 951
-24%
|
51 321
+90%
|
63 723
+24%
|
84 858
+33%
|
49 369
-42%
|
47 733
-3%
|
28 471
-40%
|
|
| Equity | |||||||||||
| Common Stock |
2 964
|
2 964
|
3 520
|
7 278
|
12 390
|
14 615
|
15 477
|
16 554
|
16 563
|
4 680
|
|
| Retained Earnings |
20 711
|
19 321
|
10 206
|
2 843
|
1 163
|
23 772
|
74 283
|
144 445
|
139 805
|
125 049
|
|
| Additional Paid In Capital |
11 518
|
11 518
|
24 116
|
22 661
|
54 638
|
72 136
|
87 094
|
106 805
|
107 006
|
106 999
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
17
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
|
| Other Equity |
0
|
7
|
0
|
988
|
15
|
326
|
632
|
1 664
|
1 258
|
2 572
|
|
| Total Equity |
35 193
N/A
|
33 810
-4%
|
37 842
+12%
|
31 794
-16%
|
65 863
+107%
|
63 305
-4%
|
28 920
-54%
|
19 424
N/A
|
17 495
+10%
|
15 945
+9%
|
|
| Total Liabilities & Equity |
41 786
N/A
|
44 542
+7%
|
73 354
+65%
|
58 745
-20%
|
117 184
+99%
|
127 028
+8%
|
113 779
-10%
|
29 946
-74%
|
30 239
+1%
|
12 526
-59%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
12
|
12
|
14
|
15
|
25
|
29
|
6
|
7
|
7
|
9
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
